mouse anti-human braf v600e monoclonal antibody (clone ve1) (Spring Bioscience)
Structured Review

Mouse Anti Human Braf V600e Monoclonal Antibody (Clone Ve1), supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-human+braf+v600e+monoclonal+antibody+(clone+ve1)/braf+v600e+antibody/pmc07801318-75-1-6
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy"
Article Title: Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy
Journal: Annals of Surgical Oncology
doi: 10.1245/s10434-020-08713-1
Figure Legend Snippet: Lymphocyte biomarkers and distribution by BRAF mutation status
Techniques Used: Mutagenesis
Figure Legend Snippet: Clinical response to DPCP correlated with OS by biomarker status
Techniques Used: Biomarker Discovery
Related Articles
Immunohistochemistry:Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing. Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined. Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases. Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis. Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1. Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China Avidin-Biotin Assay:Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing. Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined. Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases. Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis. Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1. Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China Blocking Assay:Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing. Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined. Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases. Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis. Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1. Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China Incubation:Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing. Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined. Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases. Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis. Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1. Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China Sequencing:Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing. Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined. Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases. Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis. Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1. Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China Staining:Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing. Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined. Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases. Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis. Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1. Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China Activity Assay:Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing. Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined. Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases. Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis. Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1. Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China Binding Assay:Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing. Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined. Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases. Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis. Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1. Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China |
